BRIMONIDINE

作品数：29被引量：31H指数：3
导出分析报告
相关领域：医药卫生更多>>
相关作者：赵军阳姚克尹金福吴仁毅王于蓝更多>>
相关机构：首都医科大学浙江大学医学院附属第二医院上海第二医科大学附属新华医院内蒙古医科大学更多>>
相关期刊：《Eye and Vision》《Journal of Pharmaceutical Analysis》《Aggregate》《国际眼科杂志》更多>>
相关基金：国家自然科学基金广东省自然科学基金更多>>
-
在结果中检索

检索结果分析

结果分析中...
共 条 记 录，以下是1-10
全选清除导出
参考文献引证文献引用追踪
视图：
排序：
Modification of contact lenses via metal-organic frameworks for glaucoma treatment
《Aggregate》2024年第5期358-370,共13页Alexey V.Yaremenko Roman O.Melikov Nadezhda A.Pechnikova Iaroslav B.Belyaev Alina Ringaci Tamara V.Yaremenko Aziz B.Mirkasymov Alexandr A.Tamgin Vladislav I.Rodionov Sofya M.Dolotova Grigory A.Plisko Evgeny D.Semivelichenko Anna S.Rogova Albert R.Muslimov Arina S.Ivkina Dmitry Yu.Ivkin Valery P.Erichev Sergey M.Deyev Sergey E.Avetisov Yongjiang Li Hai-Jun Liu Ivan V.Zelepukin 
Ministry of Science and Higher Education of the Russian Federation,Grant/Award Number:075-15-2024-536。
The prevention of blindness from glaucoma requires multiple treatments to lower intraocular pressure.Here,human contact lenses are modified with highly porous metal-organic frameworks with sustained release of brimonid...
关键词：BRIMONIDINE contact lenses drug delivery GLAUCOMA intraocular pressure metal-organic frameworks NANOPARTICLES 
Intravitreal brimonidine inhibits formdeprivation myopia in guinea pigs
《Eye and Vision》2023年第5期11-23,共13页Yifang Yang Junshu Wu Defu Wu Qi Wei Tan Zhong Jun Yang Xiaowei Yang Meizhen Zeng Xingwu Zhong 
This work was supported by grants from the National Natural Science Foundation of China(Grant No.81870681);the Natural Science Foundation of Hainan Province(Grant No.817364).
Background:The use of ocular hypotensive drugs has been reported to attenuate myopia progression.This study explores whether brimonidine can slow myopia progression in the guinea pig form-deprivation(FD)model.Methods:...
关键词：BRIMONIDINE MYOPIA Form deprivation RETINA 
Sustained release of brimonidine from polydimethylsiloxane-coating silicone rubber implant to reduce intraocular pressure in glaucoma
《Regenerative Biomaterials》2023年第1期968-979,共12页Chang Huang Yuening Shen Yujin Zhao Zhutian Zhang Shunxiang Gao Jiaxu Hong Jianjiang Xu Qingtao Meng Xinghuai Sun Jianguo Sun 
supported by the National Key Research and Development Program of China(2020YFA0112700);the State Key Program of National Natural Science Foundation of China(82030027);the Subject of Major Projects of National Natural Science Foundation of China(81790641);National Natural Science Foundation of China(81870630);Clinical Research Plan of SHDC(SHDC2020CR6029);the Scientific and Innovative Action Plan of Shanghai(19441900600);the Natural Science Foundation of Shanghai(19ZR1408300);the Science and Technology Commission of Shanghai Municipality(21Y11909900);Shanghai Municipal Health Commission(202240316).
Glaucoma is the leading cause of irreversible blindness,affecting 111 million people by 2040 worldwide.Intraocular pressure(IOP)is the only controllable risk factor for the disease and current treatment options seek t...
关键词：sustained release conjunctival sac implant GLAUCOMA intraocular pressure BRIMONIDINE 
Intravitreal brimonidine inhibits formdeprivation myopia in guinea pigs被引量：1
《Eye and Vision》2021年第1期263-275,共13页Yifang Yang Junshu Wu Defu Wu Qi Wei Tan Zhong Jun Yang Xiaowei Yang Meizhen Zeng Xingwu Zhong 
supported by grants from the National Natural Science Foundation of China(Grant No.81870681);the Natural Science Foundation of Hainan Province(Grant No.817364).
Background:The use of ocular hypotensive drugs has been reported to attenuate myopia progression.This study explores whether brimonidine can slow myopia progression in the guinea pig form-deprivation(FD)model.Methods:...
关键词：BRIMONIDINE MYOPIA Form deprivation RETINA 
Drug-loaded chitosan film prepared via facile solution casting and air-drying of plain water-based chitosan solution for ocular drug delivery被引量：4
《Bioactive Materials》2020年第3期577-583,共7页Boxuan Li Juan Wang Qin Gui Hu Yang 
supported,in part,by the National Institutes of Health(R01EY024072)(HY);the Fundamental Research Funds for the Central Universities(Grant No.3332019100,2019PT320028)(BL).
Chitosan is a nature-based polymer with low toxicity,excellent biocompatibility and biodegradability.However,the intractable solubility of chitosan in water and most conventional solvents hampers its biomedical applic...
关键词：CHITOSAN Plain water BRIMONIDINE GLAUCOMA Ionic liquid 
Effect of brimonidine tartrate on basophil activation in glaucoma patients被引量：1
《International Journal of Ophthalmology(English edition)》2020年第3期509-512,共4页Eldar Rosenfeld Dana Barequet Gilad Rabina Sheila Langier Moshe Lazar Gabi Shemesh Shimon Kurtz Shmuel Kivity 
AIM:To evaluate the mechanism of which brimonidine tartrate 0.15%causes clinical hypersensitivity.METHODS:A prospective case-control study comparing 8 glaucoma patients with clinical hypersensitivity to brimonidine to...
关键词：GLAUCOMA ALLERGY HYPERSENSITIVITY BRIMONIDINE TIMOLOL BASOPHILS 
Twenty-four-hour efficacy of the brinzolamide 1%/brimonidine 0.2%fixed combination:what does the new evidence tell us?
《Annals of Eye Science》2019年第1期41-44,共4页Anastasios G.Konstas Andreas Katsanos 
The importance of 24-hour intraocular pressure(IOP)assessment has increasingly being recognized in recent years(1-4).In cardiology,24-hour blood pressure monitoring is widely employed to accurately characterize a pati...
关键词：GLAUCOMA prognosis PRECISE 
Intraocular pressure with rebound tonometry and effects of topical intraocular pressure reducing medications in guinea pigs被引量：2
《International Journal of Ophthalmology(English edition)》2017年第2期186-190,共5页Yue Di Xiu-Mei Luo Tong Qiao Na Lu 
Supported by the National Natural Science Foundation of China(No.81400428);Science and Technology Commission of Shanghai Municipality(No.134119b1600)
AIM： To investigate the intraocular pressure（IOP） of adult guinea pig eyes with rebound tonometry（RBT）,and assess the effects of four distinctive topical IOP reducing medications including Carteolol,Brimonidine,B...
关键词：guinea pig intraocular pressure CARTEOLOL Brinzolamide BRIMONIDINE LATANOPROST 
Management of glaucoma in pregnancy:risks or choices,a dilemma?被引量：2
《International Journal of Ophthalmology(English edition)》2016年第11期1684-1690,共7页Harinder Singh Sethi Mayuresh Naik Vishnu Swarup Gupta 
The treatment of glaucoma in and around pregnancy offers the unique challenge of balancing the risk of vision loss to the mother as against the potential harm to the fetus or newborn. Most anti-glaucoma drugs（i.e.bet...
关键词：GLAUCOMA PREGNANCY BRIMONIDINE argonlaser trabeculoplasty-selective laser trabeculoplasty 
Clinical outcomes of combined versus separate carbachol and brimonidine drops in correcting presbyopia被引量：6
《Eye and Vision》2016年第1期239-244,共6页Almamoun Abdelkader Herbert E.Kaufman 
Background:To test and compare in a masked fashion the efficacy of using a parasympathomimetic drug(3%carbachol)and an alpha-2 agonist(0.2%brimonidine)in both combined and separate forms to create optically beneficial...
关键词：PRESBYOPIA CARBACHOL BRIMONIDINE Depth of focus MIOSIS 
全选清除导出
共3页<123>
检索报告 对象比较 聚类工具 使用帮助 返回顶部